These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


173 related items for PubMed ID: 180466

  • 1. Association of liver tumors with oral contraceptives.
    Nissen ED, Kent DR, Nissen SE, McRae DM.
    Obstet Gynecol; 1976 Jul; 48(1):49-55. PubMed ID: 180466
    [Abstract] [Full Text] [Related]

  • 2. Focal nodular hyperplasia of the liver and hepatic cell adenoma in women on oral contraceptives.
    Bartók I, Decastello A, Csikós F, Nagy I.
    Hepatogastroenterology; 1980 Dec; 27(6):435-40. PubMed ID: 6259038
    [Abstract] [Full Text] [Related]

  • 3. Hepatic adenoma and focal nodular hyperplasia.
    Shortell CK, Schwartz SI.
    Surg Gynecol Obstet; 1991 Nov; 173(5):426-31. PubMed ID: 1658955
    [Abstract] [Full Text] [Related]

  • 4. Hepatic tumors induced by sex steroids.
    Mays ET, Christopherson W.
    Semin Liver Dis; 1984 May; 4(2):147-57. PubMed ID: 6087460
    [Abstract] [Full Text] [Related]

  • 5. Liver tumors in women on contraceptive steroids.
    Christopherson WM, Mays ET, Barrows GH.
    Obstet Gynecol; 1975 Aug; 46(2):221-3. PubMed ID: 168523
    [Abstract] [Full Text] [Related]

  • 6. [A rare form of benign tumor of the liver possibly related to the use of oral contraceptives: focal pediculated nodular hyperplasia].
    Brouquet J, Chameaud J, Vire O, Fabre P, Catanzano G, Baudet JH.
    Rev Fr Gynecol Obstet; 1985 Aug; 80(8-9):621-7. PubMed ID: 2997901
    [Abstract] [Full Text] [Related]

  • 7. [Clinical, epidemiological, morphological and etiopathogenetic aspects of benign tumors of hepatocytic derivation, with description of a case of focal nodular hyperplasia].
    Bontempini L, Wittels M, Franceschini F.
    Arch De Vecchi Anat Patol; 1981 Dec; 64(3):547-68. PubMed ID: 6284066
    [Abstract] [Full Text] [Related]

  • 8. Role of oral contraceptive agents in the pathogenesis of liver tumors.
    Nissen ED, Kent DR, Nissen SE.
    J Toxicol Environ Health; 1979 Dec; 5(2-3):231-54. PubMed ID: 224197
    [Abstract] [Full Text] [Related]

  • 9. Steroid related neoplasia in human liver.
    Barrows GH, Mays ET, Christopherson WM.
    Princess Takamatsu Symp; 1987 Dec; 18():47-59. PubMed ID: 2852190
    [Abstract] [Full Text] [Related]

  • 10. Survey of primary liver tumors and oral contraceptive use.
    Vana J, Murphy GP, Aronoff BL, Baker HW.
    J Toxicol Environ Health; 1979 Dec; 5(2-3):255-73. PubMed ID: 224198
    [Abstract] [Full Text] [Related]

  • 11. Relation of steroids to liver oncogenesis.
    Christopherson WM, Mays ET.
    J Toxicol Environ Health; 1979 Dec; 5(2-3):207-30. PubMed ID: 224196
    [Abstract] [Full Text] [Related]

  • 12. [Focal nodular hyperplasia and hepatocytic adenoma in the liver of women taking contraceptive tablets].
    Bartók I, Decastella A, Csikós F, Nagy I.
    Orv Hetil; 1979 Oct 21; 120(42):2541-4. PubMed ID: 231246
    [No Abstract] [Full Text] [Related]

  • 13. Liver tumors and oral contraceptives.
    Nissen ED, Kent DR.
    Obstet Gynecol; 1975 Oct 21; 46(4):460-7. PubMed ID: 1165882
    [Abstract] [Full Text] [Related]

  • 14. Sex hormones and hepatic neoplasia.
    Goldfarb S.
    Cancer Res; 1976 Jul 21; 36(7 PT 2):2584-8. PubMed ID: 179705
    [Abstract] [Full Text] [Related]

  • 15. [Transformation of hepatic adenoma into hepatocellular carcinoma in patients with prolonged use of oral contraceptives].
    Herman P, Machado MA, Volpe P, Pugliese V, Vianna MR, Bacchella T, Machado MC, Pinotti HW.
    Rev Hosp Clin Fac Med Sao Paulo; 1994 Jul 21; 49(1):30-3. PubMed ID: 8029613
    [Abstract] [Full Text] [Related]

  • 16. [Primary malignant tumour of the liver associated with the ingestion of oral contraceptives (author's transl)].
    Leclere J, Meot B, Marchal F, Mizrahi R, Collard F, Begue JY, Rauber G, Hartemann P.
    Nouv Presse Med; 1979 Jan 27; 8(5):346-9. PubMed ID: 233379
    [Abstract] [Full Text] [Related]

  • 17. Etiologic factors in the pathogenesis of liver tumors associated with oral contraceptives.
    Nissen ED, Kent DR, Nissen SE.
    Am J Obstet Gynecol; 1977 Jan 01; 127(1):61-6. PubMed ID: 188339
    [Abstract] [Full Text] [Related]

  • 18. Oral contraceptives and cancer of the liver: a review with two additional cases.
    Helling TS, Wood WG.
    Am J Gastroenterol; 1982 Jul 01; 77(7):504-8. PubMed ID: 6283882
    [Abstract] [Full Text] [Related]

  • 19. Benign liver tumors: what is their relationship to oral contraceptives?
    Lansing PB, McQuitty JT, Bradburn DM.
    Am Surg; 1976 Oct 01; 42(10):744-60. PubMed ID: 184729
    [Abstract] [Full Text] [Related]

  • 20. Risk factors associated with the use of sex hormones.
    Taylor W.
    Anticancer Res; 1987 Oct 01; 7(5B):943-8. PubMed ID: 2829703
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.